| immune effector process | GO:0002252 | 321 | 0.087 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.086 | |
| camera type eye development | GO:0043010 | 266 | 0.074 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.067 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.066 | |
| adaptive immune response | GO:0002250 | 155 | 0.063 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.062 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.062 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.061 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.060 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.059 | |
| cell adhesion | GO:0007155 | 329 | 0.058 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.058 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.052 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.051 | |
| muscle tissue development | GO:0060537 | 308 | 0.049 | |
| cytokine production | GO:0001816 | 319 | 0.048 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.048 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.046 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.045 | |
| protein secretion | GO:0009306 | 111 | 0.045 | |
| epithelial tube formation | GO:0072175 | 130 | 0.045 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.045 | |
| fat cell differentiation | GO:0045444 | 160 | 0.044 | |
| amine metabolic process | GO:0009308 | 45 | 0.044 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.041 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.040 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.039 | |
| organelle fission | GO:0048285 | 170 | 0.039 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.039 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.039 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.039 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.038 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.035 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.035 | |
| regulation of secretion | GO:0051046 | 274 | 0.034 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.034 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.033 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.032 | |
| respiratory tube development | GO:0030323 | 167 | 0.031 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.030 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.030 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.030 | |
| gastrulation | GO:0007369 | 116 | 0.030 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.029 | |
| lung development | GO:0030324 | 164 | 0.029 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.029 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.029 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.028 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.028 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.028 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.027 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.027 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.027 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.026 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.026 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.026 | |
| histone modification | GO:0016570 | 159 | 0.025 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.025 | |
| placenta development | GO:0001890 | 140 | 0.024 | |
| heart morphogenesis | GO:0003007 | 178 | 0.024 | |
| tissue homeostasis | GO:0001894 | 115 | 0.024 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.024 | |
| protein localization to organelle | GO:0033365 | 185 | 0.023 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.023 | |
| muscle system process | GO:0003012 | 141 | 0.023 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.023 | |
| negative regulation of glial cell proliferation | GO:0060253 | 4 | 0.023 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.023 | |
| respiratory system development | GO:0060541 | 190 | 0.023 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.023 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.023 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.023 | |
| nuclear division | GO:0000280 | 158 | 0.022 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.022 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.022 | |
| tube closure | GO:0060606 | 91 | 0.022 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.022 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.022 | |
| reactive oxygen species biosynthetic process | GO:1903409 | 8 | 0.022 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.022 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.021 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.021 | |
| liver development | GO:0001889 | 66 | 0.021 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.021 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.021 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.021 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.021 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.021 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.021 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.020 | |
| regulation of chromosome organization | GO:0033044 | 83 | 0.020 | |
| cellular response to lipid | GO:0071396 | 145 | 0.020 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.020 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.020 | |
| urogenital system development | GO:0001655 | 261 | 0.019 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.019 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.019 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.019 | |
| nuclear transport | GO:0051169 | 139 | 0.019 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.019 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.019 | |
| regulation of histone modification | GO:0031056 | 56 | 0.019 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.019 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.019 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.018 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.018 | |
| regulation of cell migration | GO:0030334 | 219 | 0.018 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.018 | |
| limb morphogenesis | GO:0035108 | 149 | 0.018 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.018 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.018 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.018 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.017 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.017 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.017 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.017 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.017 | |
| cell fate commitment | GO:0045165 | 210 | 0.017 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.017 | |
| cardiac chamber development | GO:0003205 | 108 | 0.017 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.016 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.016 | |
| glial cell development | GO:0021782 | 54 | 0.016 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.016 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.016 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.016 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.016 | |
| neural tube formation | GO:0001841 | 108 | 0.016 | |
| chromatin organization | GO:0006325 | 206 | 0.016 | |
| transmembrane transport | GO:0055085 | 412 | 0.016 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.016 | |
| skeletal system development | GO:0001501 | 356 | 0.016 | |
| neural tube development | GO:0021915 | 160 | 0.016 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.016 | |
| response to light stimulus | GO:0009416 | 135 | 0.015 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.015 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.015 | |
| stem cell development | GO:0048864 | 219 | 0.015 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.015 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.015 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.015 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.015 | |
| tube formation | GO:0035148 | 140 | 0.015 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.015 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.014 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.014 | |
| inflammatory response | GO:0006954 | 244 | 0.014 | |
| chromatin modification | GO:0016568 | 187 | 0.014 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.014 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.014 | |
| protein import into nucleus | GO:0006606 | 95 | 0.014 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.014 | |
| neuronal action potential | GO:0019228 | 54 | 0.014 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.014 | |
| appendage development | GO:0048736 | 166 | 0.014 | |
| leukocyte migration | GO:0050900 | 124 | 0.014 | |
| renal tubule development | GO:0061326 | 87 | 0.014 | |
| nuclear import | GO:0051170 | 95 | 0.014 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.014 | |
| glycosylation | GO:0070085 | 62 | 0.014 | |
| regulation of chromatin modification | GO:1903308 | 57 | 0.014 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.014 | |
| regulation of protein processing | GO:0070613 | 96 | 0.014 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.013 | |
| cell chemotaxis | GO:0060326 | 81 | 0.013 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.013 | |
| extracellular structure organization | GO:0043062 | 148 | 0.013 | |
| cell cell recognition | GO:0009988 | 44 | 0.013 | |
| regulation of ion transport | GO:0043269 | 215 | 0.013 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.013 | |
| t cell activation | GO:0042110 | 289 | 0.013 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.013 | |
| organ growth | GO:0035265 | 117 | 0.013 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.013 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.013 | |
| biomineral tissue development | GO:0031214 | 64 | 0.013 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.013 | |
| regulation of protein localization | GO:0032880 | 231 | 0.013 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.013 | |
| limb development | GO:0060173 | 166 | 0.013 | |
| ossification | GO:0001503 | 216 | 0.013 | |
| single organism nuclear import | GO:1902593 | 95 | 0.013 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.013 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.013 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.013 | |
| action potential | GO:0001508 | 78 | 0.013 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.013 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.013 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.013 | |
| primary neural tube formation | GO:0014020 | 95 | 0.013 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.013 | |
| ventricular septum development | GO:0003281 | 42 | 0.013 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.012 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.012 | |
| mesonephros development | GO:0001823 | 97 | 0.012 | |
| regulation of cell division | GO:0051302 | 76 | 0.012 | |
| membrane organization | GO:0061024 | 245 | 0.012 | |
| chemotaxis | GO:0006935 | 247 | 0.012 | |
| calcium ion transport | GO:0006816 | 159 | 0.012 | |
| regulation of chromatin organization | GO:1902275 | 57 | 0.012 | |
| regulation of actin filament based process | GO:0032970 | 99 | 0.012 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.012 | |
| cell division | GO:0051301 | 120 | 0.012 | |
| regulation of cell motility | GO:2000145 | 236 | 0.012 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.012 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.012 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.012 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.012 | |
| dna metabolic process | GO:0006259 | 303 | 0.012 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.012 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.012 | |
| drug metabolic process | GO:0017144 | 4 | 0.012 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.012 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.012 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.012 | |
| regulation of production of molecular mediator of immune response | GO:0002700 | 65 | 0.011 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.011 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.011 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.011 | |
| mesoderm development | GO:0007498 | 100 | 0.011 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.011 | |
| multicellular organism growth | GO:0035264 | 161 | 0.011 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.011 | |
| gliogenesis | GO:0042063 | 141 | 0.011 | |
| pancreas development | GO:0031016 | 57 | 0.011 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.011 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.011 | |
| embryonic placenta development | GO:0001892 | 98 | 0.011 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.011 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.011 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.011 | |
| cation homeostasis | GO:0055080 | 212 | 0.011 | |
| regulation of cell activation | GO:0050865 | 289 | 0.011 | |
| stem cell proliferation | GO:0072089 | 117 | 0.011 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.011 | |
| ureteric bud development | GO:0001657 | 94 | 0.011 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.011 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.011 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.011 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.011 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.011 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.011 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.011 | |
| regulation of protein transport | GO:0051223 | 163 | 0.011 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.011 | |
| negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | GO:0072040 | 4 | 0.010 | |
| intracellular protein transport | GO:0006886 | 204 | 0.010 | |
| regulation of interleukin 13 secretion | GO:2000665 | 2 | 0.010 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.010 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.010 | |
| compound eye development | GO:0048749 | 1 | 0.010 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.010 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.010 | |
| g protein coupled acetylcholine receptor signaling pathway | GO:0007213 | 4 | 0.010 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.010 | |
| retinal blood vessel morphogenesis | GO:0061304 | 3 | 0.010 | |
| bone mineralization | GO:0030282 | 54 | 0.010 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.010 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.010 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.010 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.010 | |
| calcium ion transmembrane transport | GO:0070588 | 85 | 0.010 | |